GEA Group (G1AG.DE) - Leading Technology Supplier For Food And Pharma

Goldman Sachs initiates coverage on GEA Group at Neutral with a €56 price target. The report highlights GEA's leading position in food, beverage, and pharmaceutical process technology, balanced against a valuation that fully accounts for its growth outlook.

Key Takeaways

• 1.Initiating coverage of GEA Group with a Neutral rating and 12-month target price of €56.
• 2.GEA benefits from resilient margin profile and aftermarket services, but current valuation is considered fair.

Table of Contents

• Investment thesis in charts
• Company profile
• GEA Toolkit
• Company overview: Leading global supplier of food and pharmaceutical process technology
• History at a glance
• Divisional and geographical split
• Product summary
• Raw materials & production
• Research & Development
• Customer base
• End market competitive landscape
• Market outlook
• Bottom-up forecasting
• Key financials
• Bull/Bear scenario analysis
• GEA Group vs. European Multi-Industry
• Valuation
• GS SUSTAIN - Sustainability analysis of GEA group
• Key risks
• Disclosure Appendix

Document Preview

Page 1 of 5

Subscribe for full accessStart Free Trial